Cartesian Therapeutics
RNAC
RNAC
72 hedge funds and large institutions have $86.7M invested in Cartesian Therapeutics in 2025 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 19 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
+4
Holders Change %
+5.88%
% of All Funds
0.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
22
Reduced
19
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
EAM
Erste Asset Management
Vienna,
Austria
|
+$1.14M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$976K |
| 3 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$918K |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$509K |
| 5 |
State Street
Boston,
Massachusetts
|
+$376K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$2.21M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.1M |
| 3 |
JPMorgan Chase & Co
New York
|
-$1.05M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$395K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$260K |
